Anti-retroviral Therapy - Part 4: Post and Pre-Exposure Prophylaxis for HIV

#HIV #Retrovirus #RNA #AIDS #treatment #Immunodefficiency #prophylaxis #pre #post #lenacapavir #cabotegravir #NACO #CDC #WHO

Link for Joining the Channel: https://www.youtube.com/channel/UC0GlnmHFUbzONmKqeNOqf4Q/join

Introduction - 01:09
Indications of PEP - 03:30
Risk from body fluids - 05:25
PEP CDC Guidelines - 07:30
PEP NACO 2022 Guidelines: Adults - 09:09
PEP NACO 2022 Guidelines: Children - 12:46
Pre-Exposure Prophylaxis Pr-EP] for HIV - 15:11
Pr-EP [CDC] - 16:19
Pr-EP [NACO] - 18:35
Further Reading - 19:53
Membership of the Channel - 20:42
End - 21:17

Further Reading:

1. Https://hivinfo.nih.gov/understanding-hiv/fact-sheets/fda-approved-hiv-medicines

2. National Guidelines for HIV Care and Treatment, 2021. New Delhi: NACO, Ministry of Health and Family Welfare, Government of India

3. Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV — CDC Recommendations, United States, 2025

4. https://naco.gov.in/sites/default/files/National_Guidelines_for_HIV_Care_and_Treatment_2021.pdf

5. Lenacapavir WHO Guidelines: https://www.who.int/publications/i/item/9789240111608

Видео Anti-retroviral Therapy - Part 4: Post and Pre-Exposure Prophylaxis for HIV канала SkinSire